Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Jun 27, 20250
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Michael Camilleri, MD
Guest: Michael Camilleri, MD
GLP-1 receptor agonists are revolutionizing treatment for diabetes and obesity, but their impact on the gastrointestinal tract demands careful clinical attention. Dr. Peter Buch is joined by Dr. Michael Camilleri, Professor of Medicine at the Mayo Foundation for Medical Education and Research in Rochester, Minnesota, to discuss key findings on gastrointestinal side effects, procedural risks, and the impacts of GLP-1 receptor agonists on the fields of gastroenterology and hepatology.
For the best experience, listen in Metacast app for iOS or Android